Connection

CHANGYI CHEN to Humans

This is a "connection" page, showing publications CHANGYI CHEN has written about Humans.
Connection Strength

0.740
  1. Roles of cardiovascular risk factors in endothelial nitric oxide synthase regulation: an update. Curr Pharm Des. 2014; 20(22):3563-78.
    View in: PubMed
    Score: 0.012
  2. Anti-human protein S antibody induces tissue factor expression through a direct interaction with platelet phosphofructokinase. Thromb Res. 2014 Feb; 133(2):222-8.
    View in: PubMed
    Score: 0.012
  3. Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine. Med Sci Monit. 2013 Oct 31; 19:916-26.
    View in: PubMed
    Score: 0.012
  4. Suppression of thymosin ?10 increases cell migration and metastasis of cholangiocarcinoma. BMC Cancer. 2013 Sep 23; 13:430.
    View in: PubMed
    Score: 0.012
  5. Roles and mechanisms of ?-thymosins in cell migration and cancer metastasis: an update. Cancer Invest. 2013 Feb; 31(2):103-10.
    View in: PubMed
    Score: 0.012
  6. Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Atherosclerosis. 2012 May; 222(1):74-83.
    View in: PubMed
    Score: 0.011
  7. Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol. 2012 Feb; 165(3):622-32.
    View in: PubMed
    Score: 0.011
  8. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma. Mol Cancer. 2011 Aug 26; 10:102.
    View in: PubMed
    Score: 0.011
  9. Expression and function of a large non-coding RNA gene XIST in human cancer. World J Surg. 2011 Aug; 35(8):1751-6.
    View in: PubMed
    Score: 0.010
  10. Roles and mechanisms of microRNAs in pancreatic cancer. World J Surg. 2011 Aug; 35(8):1725-31.
    View in: PubMed
    Score: 0.010
  11. Overview of the development of personalized genomic medicine and surgery. World J Surg. 2011 Aug; 35(8):1693-9.
    View in: PubMed
    Score: 0.010
  12. Transforming growth factor-beta increases the expression of vascular smooth muscle cell markers in human multi-lineage progenitor cells. Med Sci Monit. 2011 Feb 25; 17(3):BR55-61.
    View in: PubMed
    Score: 0.010
  13. MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med. 2011 Jan; 15(1):14-23.
    View in: PubMed
    Score: 0.010
  14. miRNAs: roles and clinical applications in vascular disease. Expert Rev Mol Diagn. 2011 Jan; 11(1):79-89.
    View in: PubMed
    Score: 0.010
  15. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol. 2010 Jul; 299(1):H193-201.
    View in: PubMed
    Score: 0.010
  16. Role of somatic mutations in vascular disease formation. Expert Rev Mol Diagn. 2010 Mar; 10(2):173-85.
    View in: PubMed
    Score: 0.010
  17. HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells. Cardiovasc Res. 2010 Jul 15; 87(2):366-74.
    View in: PubMed
    Score: 0.009
  18. Arterial baroreceptors in the management of systemic hypertension. Med Sci Monit. 2010 Jan; 16(1):RA1-8.
    View in: PubMed
    Score: 0.009
  19. Advances in thymosin beta10 research: differential expression, molecular mechanisms, and clinical implications in cancer and other conditions. Cancer Invest. 2009 Dec; 27(10):1016-22.
    View in: PubMed
    Score: 0.009
  20. The soybean isoflavonoid equol blocks ritonavir-induced endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells. J Nutr. 2010 Jan; 140(1):12-7.
    View in: PubMed
    Score: 0.009
  21. Cyclophilin A: potential functions and therapeutic target for human cancer. Med Sci Monit. 2009 Nov; 15(11):RA221-32.
    View in: PubMed
    Score: 0.009
  22. Eotaxin increases monolayer permeability of human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol. 2009 Dec; 29(12):2146-52.
    View in: PubMed
    Score: 0.009
  23. Highly active antiretroviral therapy drugs inhibit in vitro cholesterol efflux from human macrophage-derived foam cells. Lab Invest. 2009 Dec; 89(12):1355-63.
    View in: PubMed
    Score: 0.009
  24. Lactosylceramide causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Med Sci Monit. 2009 Sep; 15(9):BR270-4.
    View in: PubMed
    Score: 0.009
  25. Non-nucleoside reverse transcriptase inhibitor efavirenz increases monolayer permeability of human coronary artery endothelial cells. Atherosclerosis. 2010 Jan; 208(1):104-11.
    View in: PubMed
    Score: 0.009
  26. Lactosylceramide promotes cell migration and proliferation through activation of ERK1/2 in human aortic smooth muscle cells. Am J Physiol Heart Circ Physiol. 2009 Jul; 297(1):H400-8.
    View in: PubMed
    Score: 0.009
  27. Chlamydia heat shock protein 60 decreases expression of endothelial nitric oxide synthase in human and porcine coronary artery endothelial cells. Cardiovasc Res. 2009 Sep 01; 83(4):768-77.
    View in: PubMed
    Score: 0.009
  28. MicroRNAs: control and loss of control in human physiology and disease. World J Surg. 2009 Apr; 33(4):667-84.
    View in: PubMed
    Score: 0.009
  29. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg. 2009 Apr; 33(4):698-709.
    View in: PubMed
    Score: 0.009
  30. Overview of the Molecular Surgeon Symposium on Personalized Genomic Medicine and Surgery. World J Surg. 2009 Apr; 33(4):612-4.
    View in: PubMed
    Score: 0.009
  31. HIV Nef protein causes endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells. J Surg Res. 2009 Oct; 156(2):257-64.
    View in: PubMed
    Score: 0.009
  32. Roles and mechanisms of copper transporting ATPases in cancer pathogenesis. Med Sci Monit. 2009 Jan; 15(1):RA1-5.
    View in: PubMed
    Score: 0.009
  33. Growth hormone-releasing peptide ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells. J Vasc Surg. 2009 Jan; 49(1):199-207.
    View in: PubMed
    Score: 0.009
  34. Serum amyloid A induces endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol. 2008 Dec; 295(6):H2399-408.
    View in: PubMed
    Score: 0.009
  35. Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages. Blood. 2009 Jan 01; 113(1):165-74.
    View in: PubMed
    Score: 0.009
  36. Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells. Blood. 2008 Oct 15; 112(8):3205-16.
    View in: PubMed
    Score: 0.009
  37. Recent advances in molecular mechanisms of abdominal aortic aneurysm formation. World J Surg. 2008 Jun; 32(6):976-86.
    View in: PubMed
    Score: 0.008
  38. Nitrotyrosine promotes human aortic smooth muscle cell migration through oxidative stress and ERK1/2 activation. Biochim Biophys Acta. 2008 Sep; 1783(9):1576-84.
    View in: PubMed
    Score: 0.008
  39. Human stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol. 2008 May; 28(5):906-12.
    View in: PubMed
    Score: 0.008
  40. Chlorotyrosine promotes human aortic smooth muscle cell migration through increasing superoxide anion production and ERK1/2 activation. Atherosclerosis. 2008 Nov; 201(1):67-75.
    View in: PubMed
    Score: 0.008
  41. C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):519-26.
    View in: PubMed
    Score: 0.008
  42. Ceramide: a common pathway for atherosclerosis? Atherosclerosis. 2008 Feb; 196(2):497-504.
    View in: PubMed
    Score: 0.008
  43. C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells. Thromb Res. 2008; 122(1):125-33.
    View in: PubMed
    Score: 0.008
  44. Recent advances in tumor hypoxia: tumor progression, molecular mechanisms, and therapeutic implications. Med Sci Monit. 2007 Oct; 13(10):RA175-80.
    View in: PubMed
    Score: 0.008
  45. Growth-related oncogene-alpha induces endothelial dysfunction through oxidative stress and downregulation of eNOS in porcine coronary arteries. Am J Physiol Heart Circ Physiol. 2007 Nov; 293(5):H3088-95.
    View in: PubMed
    Score: 0.008
  46. Human immunodeficiency virus protease inhibitor ritonavir inhibits cholesterol efflux from human macrophage-derived foam cells. Am J Pathol. 2007 Jul; 171(1):304-14.
    View in: PubMed
    Score: 0.008
  47. Growth related oncogene-alpha (GRO-alpha): roles in atherosclerosis, angiogenesis and other inflammatory conditions. Med Sci Monit. 2007 Jun; 13(6):RA87-90.
    View in: PubMed
    Score: 0.008
  48. Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res. 2006 Apr 01; 70(1):146-57.
    View in: PubMed
    Score: 0.007
  49. Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J Surg Res. 2006 Jun 15; 133(2):143-9.
    View in: PubMed
    Score: 0.007
  50. Effects of homocysteine and ginsenoside Rb1 on endothelial proliferation and superoxide anion production. J Surg Res. 2006 Jun 15; 133(2):89-94.
    View in: PubMed
    Score: 0.007
  51. Effects of lysophosphatidylcholine on monolayer cell permeability of human coronary artery endothelial cells. Surgery. 2005 Sep; 138(3):464-73.
    View in: PubMed
    Score: 0.007
  52. Review: application of stem cells for vascular tissue engineering. Tissue Eng. 2005 Sep-Oct; 11(9-10):1535-52.
    View in: PubMed
    Score: 0.007
  53. C-reactive protein decreases expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Surgery. 2005 Aug; 138(2):212-22.
    View in: PubMed
    Score: 0.007
  54. Effects of HIV protease inhibitor ritonavir on vasomotor function and endothelial nitric oxide synthase expression. J Acquir Immune Defic Syndr. 2005 Jun 01; 39(2):152-8.
    View in: PubMed
    Score: 0.007
  55. Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease. J Surg Res. 2005 Jun 01; 126(1):121-9.
    View in: PubMed
    Score: 0.007
  56. Roles of hemodynamic forces in vascular cell differentiation. Ann Biomed Eng. 2005 Jun; 33(6):772-9.
    View in: PubMed
    Score: 0.007
  57. Roles of neuropilins in neuronal development, angiogenesis, and cancers. World J Surg. 2005 Mar; 29(3):271-5.
    View in: PubMed
    Score: 0.007
  58. Roles of thymosins in cancers and other organ systems. World J Surg. 2005 Mar; 29(3):264-70.
    View in: PubMed
    Score: 0.007
  59. Roles of cyclophilins in cancers and other organ systems. World J Surg. 2005 Mar; 29(3):276-80.
    View in: PubMed
    Score: 0.007
  60. TNF-alpha decreases expression of somatostatin, somatostatin receptors, and cortistatin in human coronary endothelial cells. J Surg Res. 2005 Feb; 123(2):294-301.
    View in: PubMed
    Score: 0.007
  61. Effects of cyclophilin A on cell proliferation and gene expressions in human vascular smooth muscle cells and endothelial cells. J Surg Res. 2005 Feb; 123(2):312-9.
    View in: PubMed
    Score: 0.007
  62. Cellular and molecular mechanisms of coronary vessel development. Vasc Med. 2005 Feb; 10(1):37-44.
    View in: PubMed
    Score: 0.007
  63. Defensins and cathelicidins: neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis. J Cell Mol Med. 2005 Jan-Mar; 9(1):3-10.
    View in: PubMed
    Score: 0.007
  64. Expression and regulation of neuropilins and VEGF receptors by TNF-alpha in human endothelial cells. J Surg Res. 2004 Dec; 122(2):249-55.
    View in: PubMed
    Score: 0.007
  65. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer. 2004 Nov 15; 101(10):2341-50.
    View in: PubMed
    Score: 0.007
  66. Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thromb Res. 2005; 115(5):417-26.
    View in: PubMed
    Score: 0.007
  67. Characterization of two populations of human coronary artery endothelial cells(1). J Surg Res. 2004 May 01; 118(1):38-44.
    View in: PubMed
    Score: 0.006
  68. Clinical use and molecular mechanisms of action of extract of Ginkgo biloba leaves in cardiovascular diseases. Cardiovasc Drug Rev. 2004; 22(4):309-19.
    View in: PubMed
    Score: 0.006
  69. HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells. Lab Invest. 2002 Mar; 82(3):245-55.
    View in: PubMed
    Score: 0.005
  70. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. Virology. 2001 Jun 20; 285(1):128-37.
    View in: PubMed
    Score: 0.005
  71. Production and characterization of simian--human immunodeficiency virus-like particles. AIDS Res Hum Retroviruses. 2000 Feb 10; 16(3):227-36.
    View in: PubMed
    Score: 0.005
  72. Effects of homocysteine on smooth muscle cell proliferation in both cell culture and artery perfusion culture models. J Surg Res. 2000 Jan; 88(1):26-33.
    View in: PubMed
    Score: 0.005
  73. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures. J Surg Res. 1998 Feb 15; 75(1):35-41.
    View in: PubMed
    Score: 0.004
  74. Boundary layer infusion of basic fibroblast growth factor accelerates intimal hyperplasia in endarterectomized canine artery. J Surg Res. 1997 May; 69(2):300-6.
    View in: PubMed
    Score: 0.004
  75. Tenascin: a potential role in human arteriovenous PTFE graft failure. J Surg Res. 1996 Feb 01; 60(2):409-16.
    View in: PubMed
    Score: 0.004
  76. "Click" immobilization of a VEGF-mimetic peptide on decellularized endothelial extracellular matrix to enhance angiogenesis. ACS Appl Mater Interfaces. 2014 Jun 11; 6(11):8401-6.
    View in: PubMed
    Score: 0.003
  77. The Effect of Lipid Modification on Peripheral Artery Disease after Endovascular Intervention Trial (ELIMIT). Atherosclerosis. 2013 Dec; 231(2):371-7.
    View in: PubMed
    Score: 0.003
  78. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Clin Cancer Res. 2013 Nov 01; 19(21):5901-13.
    View in: PubMed
    Score: 0.003
  79. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. EMBO Mol Med. 2013 Sep; 5(9):1322-34.
    View in: PubMed
    Score: 0.003
  80. Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells. PLoS One. 2013; 8(7):e68303.
    View in: PubMed
    Score: 0.003
  81. Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium. PLoS One. 2013; 8(5):e63702.
    View in: PubMed
    Score: 0.003
  82. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug; 18(8):BR293-298.
    View in: PubMed
    Score: 0.003
  83. Natural antioxidant dihydroxybenzyl alcohol blocks ritonavir-induced endothelial dysfunction in porcine pulmonary arteries and human endothelial cells. Med Sci Monit. 2011 Sep; 17(9):BR235-41.
    View in: PubMed
    Score: 0.003
  84. Mesothelin confers pancreatic cancer cell resistance to TNF-a-induced apoptosis through Akt/PI3K/NF-?B activation and IL-6/Mcl-1 overexpression. Mol Cancer. 2011 Aug 31; 10:106.
    View in: PubMed
    Score: 0.003
  85. Defining the cancer master switch. World J Surg. 2011 Aug; 35(8):1738-45.
    View in: PubMed
    Score: 0.003
  86. Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation. Carcinogenesis. 2011 Jul; 32(7):1013-24.
    View in: PubMed
    Score: 0.003
  87. Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer. J Immunother. 2011 Apr; 34(3):251-63.
    View in: PubMed
    Score: 0.003
  88. Overcoming drug resistance in pancreatic cancer. Expert Opin Ther Targets. 2011 Jul; 15(7):817-28.
    View in: PubMed
    Score: 0.003
  89. PDX-1: demonstration of oncogenic properties in pancreatic cancer. Cancer. 2011 Feb 15; 117(4):723-33.
    View in: PubMed
    Score: 0.002
  90. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol Cancer. 2010 Sep 21; 9:253.
    View in: PubMed
    Score: 0.002
  91. Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV. Vaccine. 2010 Jul 12; 28(31):5114-27.
    View in: PubMed
    Score: 0.002
  92. Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit. 2010 May; 16(5):RA93-100.
    View in: PubMed
    Score: 0.002
  93. ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts. Cancer Biol Ther. 2010 Feb; 9(3):236-42.
    View in: PubMed
    Score: 0.002
  94. ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res. 2010 Mar 01; 16(5):1423-30.
    View in: PubMed
    Score: 0.002
  95. Targeted drug delivery in pancreatic cancer. Biochim Biophys Acta. 2010 Jan; 1805(1):97-104.
    View in: PubMed
    Score: 0.002
  96. Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res. 2009 Oct 01; 15(19):5993-6001.
    View in: PubMed
    Score: 0.002
  97. Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med. 2010 Apr; 14(4):840-60.
    View in: PubMed
    Score: 0.002
  98. Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim Biophys Acta. 2009 Dec; 1796(2):309-14.
    View in: PubMed
    Score: 0.002
  99. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 2009 Jul; 7(3):293-302.
    View in: PubMed
    Score: 0.002
  100. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn. 2009 May; 9(4):325-41.
    View in: PubMed
    Score: 0.002
  101. Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD). Platelets. 2009 May; 20(3):199-205.
    View in: PubMed
    Score: 0.002
  102. Current understanding and potential immunotherapy for HIV-associated squamous cell carcinoma of the anus (SCCA). World J Surg. 2009 Apr; 33(4):653-60.
    View in: PubMed
    Score: 0.002
  103. Basic principles and technologies for deciphering the genetic map of cancer. World J Surg. 2009 Apr; 33(4):615-29.
    View in: PubMed
    Score: 0.002
  104. Developing a tissue resource to characterize the genome of pancreatic cancer. World J Surg. 2009 Apr; 33(4):723-31.
    View in: PubMed
    Score: 0.002
  105. Thymosin beta-10 is aberrantly expressed in pancreatic cancer and induces JNK activation. Cancer Invest. 2009 Mar; 27(3):251-6.
    View in: PubMed
    Score: 0.002
  106. Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3. Mol Cancer Res. 2008 Nov; 6(11):1755-65.
    View in: PubMed
    Score: 0.002
  107. Somatostatin receptor-1 induces cell cycle arrest and inhibits tumor growth in pancreatic cancer. Cancer Sci. 2008 Nov; 99(11):2218-23.
    View in: PubMed
    Score: 0.002
  108. Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications. Expert Opin Ther Targets. 2008 May; 12(5):637-45.
    View in: PubMed
    Score: 0.002
  109. Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells. J Surg Res. 2008 Jul; 148(1):17-23.
    View in: PubMed
    Score: 0.002
  110. Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer. Cancer Sci. 2008 Apr; 99(4):733-7.
    View in: PubMed
    Score: 0.002
  111. Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther. 2008 Feb; 7(2):286-96.
    View in: PubMed
    Score: 0.002
  112. Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation. Cancer Biol Ther. 2008 Mar; 7(3):419-23.
    View in: PubMed
    Score: 0.002
  113. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A. 2007 Nov 20; 104(47):18636-41.
    View in: PubMed
    Score: 0.002
  114. IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells. Cancer Biol Ther. 2007 Jul; 6(7):1096-100.
    View in: PubMed
    Score: 0.002
  115. Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res. 2007 Jun 01; 67(11):5479-88.
    View in: PubMed
    Score: 0.002
  116. Effect of cyclophilin A on gene expression in human pancreatic cancer cells. Am J Surg. 2005 Nov; 190(5):739-45.
    View in: PubMed
    Score: 0.002
  117. Virus-like particles as HIV-1 vaccines. Rev Med Virol. 2005 Mar-Apr; 15(2):75-88.
    View in: PubMed
    Score: 0.002
  118. Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications. World J Surg. 2005 Mar; 29(3):297-305.
    View in: PubMed
    Score: 0.002
  119. Somatostatin, somatostatin receptors, and pancreatic cancer. World J Surg. 2005 Mar; 29(3):293-6.
    View in: PubMed
    Score: 0.002
  120. Anastomotic strategies to improve hemodialysis access patency--a review. Vasc Endovascular Surg. 2005 Mar-Apr; 39(2):135-42.
    View in: PubMed
    Score: 0.002
  121. Abdominal aortic surgery in patients with human immunodeficiency virus infection. Am J Surg. 2004 Dec; 188(6):690-7.
    View in: PubMed
    Score: 0.002
  122. SHIV virus-like particles bind and activate human dendritic cells. Vaccine. 2004 Nov 25; 23(2):139-47.
    View in: PubMed
    Score: 0.002
  123. Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR. J Surg Res. 2004 Jun 15; 119(2):130-7.
    View in: PubMed
    Score: 0.002
  124. What is new in the preoperative evaluation of arteriovenous access operation? Semin Vasc Surg. 2004 Mar; 17(1):57-63.
    View in: PubMed
    Score: 0.002
  125. Impact of an endovascular program on the operative experience of abdominal aortic aneurysm in vascular fellowship and general surgery residency. Am J Surg. 2003 Aug; 186(2):189-93.
    View in: PubMed
    Score: 0.002
  126. Epidural analgesia in patients with chronic obstructive pulmonary disease undergoing transperitoneal abdominal aortic aneurysmorraphy--a multi-institutional analysis. Cardiovasc Surg. 2003 Jun; 11(3):179-84.
    View in: PubMed
    Score: 0.001
  127. Intraaortic stabilization of the AneuRx stent-graft system: a useful adjunct to minimize device migration. Cardiovasc Intervent Radiol. 2003 Jan-Feb; 26(1):73-5.
    View in: PubMed
    Score: 0.001
  128. The regained referral ground and clinical practice of vena cava filter placement in vascular surgery. Am Surg. 2002 Oct; 68(10):865-70.
    View in: PubMed
    Score: 0.001
  129. A prospective evaluation of hypogastric artery embolization in endovascular aortoiliac aneurysm repair. J Vasc Surg. 2002 Sep; 36(3):500-6.
    View in: PubMed
    Score: 0.001
  130. Late complication of aortoiliac stent placement- atheroembolization of the lower extremities. J Surg Res. 2002 Apr; 103(2):153-9.
    View in: PubMed
    Score: 0.001
  131. Surgical intervention for complications caused by femoral artery catheterization in pediatric patients. J Vasc Surg. 2001 Dec; 34(6):1071-8.
    View in: PubMed
    Score: 0.001
  132. Incidence and characteristics of patients with hand ischemia after a hemodialysis access procedure. J Surg Res. 1998 Jan; 74(1):8-10.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.